During the past decade, St. Vincenz und Elisabeth Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Vincenz und Elisabeth Hospital" #1 sponsor was "Bayer" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company" with 1 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials sponsored and "Heinrich-Heine University, Duesseldorf" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Vincenz und Elisabeth Hospital" #1 collaborator was "German Breast Group" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "St. Vincenz und Elisabeth Hospital" are "Breast Cancer" (5 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Cardiovascular Diseases" (1 trials), "Chronic Heart Failure With Preserved Ejection Fraction" (1 trials) and "Dyslipidemic" (1 trials). Many other conditions were trialed in "St. Vincenz und Elisabeth Hospital" in a lesser frequency.

Most popular intervention types in "St. Vincenz und Elisabeth Hospital" are "Drug" (10 trials), "Biological" (3 trials), "Other" (3 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials), "Cyclophosphamide" (2 trials), "Placebo" (2 trials), "Trastuzumab" (2 trials) and "cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "St. Vincenz und Elisabeth Hospital" are 6 trials for "Female" genders and 5 trials for "All" genders.

Currently, there are NaN active trials in "St. Vincenz und Elisabeth Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in St. Vincenz und Elisabeth Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in St. Vincenz und Elisabeth Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".